New aspects as to development, testing, manufacture and marketing authorization application of herbal medicinal products/proceedings of phytopharmaka

被引：0

作者：

Sievers, Hartwig ^{[1
]}

机构：

[1] PhytoLab GmbH & Co KG, D-91487 Vestenbergsgreuth, Germany

来源：

PHARMAZEUTISCHE INDUSTRIE | 2007年 / 69卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：866 / +

页数：4

共 6 条

[1] Drug safety aspects of herbal medicinal products [Arzneimittelsicherheit bei Phytopharmaka]
Wegener T.
Deitelhoff B.
Silber-Mankowsky A.
[J]. Wiener Medizinische Wochenschrift, 2015, 165 (11-12) : 243 - 250
[2] Up-to-date aspects in development, testing, production and marketing authorization application of phytopharmaceuticals
Podpetschnig-Fopp, Elke
[J]. PHARMAZEUTISCHE INDUSTRIE, 2006, 68 (07): : 887 - 888
[3] Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products - Application to Oleuropein Preparations
Lemonakis, Nikolaos
Gikas, Evagelos
Halabalaki, Maria
Skaltsounis, Alexios-Leandros
[J]. PLOS ONE, 2013, 8 (10):
[4] Hybrid or Mixed Marketing Authorization Application in the European Union: Not a Trivial Decision in New Development Programs for Established Drugs
Andreas M. Vogel
[J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 : 479 - 484
[5] Hybrid or Mixed Marketing Authorization Application in the European Union: Not a Trivial Decision in New Development Programs for Established Drugs
Vogel, Andreas M.
[J]. DRUG INFORMATION JOURNAL, 2012, 46 (04): : 479 - 484
[6] Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021
Naumann-Winter, Frauke
Wolter, Franziska
Hermes, Ulrike
Malikova, Eva
Lilienthal, Nils
Meier, Tania
Kalland, Maria Elisabeth
Magrelli, Armando
[J]. FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 →